Entellus Medical (ENTL) Misses Q4 EPS by 1c

Entellus Medical (NASDAQ: ENTL) reported Q4 EPS of ($0.27), $0.01 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $18.1 million versus the consensus estimate of $17.52 million.

GUIDANCE:

Entellus Medical sees FY2016 revenue of $73-77 million, versus the consensus of $74 million.

For earnings history and earnings-related data on Entellus Medical (ENTL) click here.

You May Also Be Interested In

• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
• Advance Auto Parts (AAP) Tops Q2 EPS by 22c; lifrs profit guidance
• Deere & Co. (DE) Tops Q3 EPS by 41c, raises guidance